Data / Drug companies / Curology
Curology: 13 products in the FDA NDC directory, labeler code 82575
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Curology (labeler code 82575) lists 13 products in the FDA National Drug Code Directory, covering 6 finished drugs by generic name. By type: 13 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on March 25, 2026.
The request: Watch Curology (FDA labeler code 82575): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 82575
- Products in commercial distribution
- 13
- Packages
- 18
- Finished drugs by generic name
- 6
- Prescription products
- 0
- Over the counter products
- 13
- Flagged as original packager
- 13 of 13 products that carry the flag
- Started marketing in the last 12 months
- 3
- Earliest marketing start
- July 16, 2022
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 13 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 13 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Salicylic acid | 5 | 330 |
| Zinc oxide | 3 | 595 |
| Titanium dioxide, zinc oxide | 2 | 255 |
| Skin barrier balm | 1 | 1 |
| Avobenzone, homosalate, octisalate, octocrylene | 1 | 157 |
| Avobenzone, homosalate, octocrylene, octisalate | 1 | 11 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Cream | 6 | 46.2% |
| Soap | 3 | 23.1% |
| Ointment | 1 | 7.7% |
| Stick | 1 | 7.7% |
| Liquid | 1 | 7.7% |
| Gel | 1 | 7.7% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
| Class | Products |
|---|---|
| Copper Absorption Inhibitor | 5 |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Silkscreen Sheer Tint Mineral Medium-Dark | 82575-039 | Cream | Over the counter monograph drugs | March 25, 2026 |
| Silkscreen Sheer Tint Mineral Light-Medium | 82575-038 | Cream | Over the counter monograph drugs | March 25, 2026 |
| Acne Cleanser | 82575-510 | Liquid | Over the counter monograph drugs | December 9, 2025 |
| Curology Acne-Clearing Gel Serum | 82575-500 | Gel | Over the counter monograph drugs | September 10, 2025 |
| Curology Daily Moisturizing | 82575-400 | Cream | Over the counter monograph drugs | August 18, 2025 |
| Curology Daily Moisturizing Sunscreen SPF 30 | 82575-036 | Cream | Over the counter monograph drugs | July 1, 2025 |
| Acne Body Wash | 82575-110 | Soap | Over the counter monograph drugs | December 1, 2023 |
| Curology Barrier Balm | 82575-302 | Ointment | Over the counter monograph drugs | October 2, 2023 |
| Acne Body Wash | 82575-200 | Soap | Over the counter monograph drugs | December 5, 2022 |
| Acne Body Wash | 82575-100 | Soap | Over the counter monograph drugs | December 5, 2022 |
| Curology Everyday Sunscreen Broad Spectrum SPF 30 No-clog UV defense | 82575-035 | Cream | Over the counter monograph drugs | December 1, 2022 |
| Curology The Lip Balm Broad Spectrum SPF 30 Sunscreen | 82575-034 | Stick | Over the counter monograph drugs | July 16, 2022 |
| Curology the sunscreen broad spectrum SPF 30 | 82575-032 | Cream | Over the counter monograph drugs | July 16, 2022 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.